Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why is SCA12 different from other SCAs?

S E Holmes1, E O'Hearn, R L Margolis

  • 1Department of Psychiatry, Hopkins University School of Medicine, Baltimore, MD, USA. seholmes@jhmi.edu

Cytogenetic and Genome Research
|October 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [<sup>11</sup>C](R)-PK11195 positron emission tomography study.

Molecular psychiatry·2016
Same author

Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.

AJNR. American journal of neuroradiology·2015
Same author

Review of the 2012 Epizootic Hemorrhagic Disease Outbreak in Domestic Ruminants in the United States.

PloS one·2015
Same author

Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant.

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2013
Same author

A mutation in NPAS3 segregates with mental illness in a small family.

Molecular psychiatry·2013
Same author

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

Neurology·2012

Spinocerebellar ataxia type 12 (SCA12) presents with early action tremor and variable symptoms. Genetic analysis reveals a CAG repeat expansion, distinct from polyglutamine disorders, potentially impacting PPP2R2B gene expression.

Area of Science:

  • Neurogenetics
  • Neurology
  • Molecular Biology

Background:

  • Spinocerebellar ataxia type 12 (SCA12) is a rare neurodegenerative disorder.
  • It affects individuals of European-American and Asian (Indian) descent.
  • SCA12 exhibits unique clinical, pathological, and molecular characteristics compared to other spinocerebellar ataxias.

Purpose of the Study:

  • To delineate the distinct features of Spinocerebellar ataxia type 12 (SCA12).
  • To investigate the genetic basis and molecular underpinnings of SCA12.

Main Methods:

  • Clinical assessment of affected individuals.
  • Brain Magnetic Resonance Imaging (MRI) for pathological evaluation.
  • Genetic analysis to identify causative mutations.

Related Experiment Videos

Main Results:

  • SCA12 is clinically characterized by early and prominent action tremor, with variable other neurological signs.
  • Pathological findings include prominent cortical and cerebellar atrophy on brain MRI.
  • Genetic analysis identified a CAG repeat expansion not encoding polyglutamine, suggesting a novel pathogenic mechanism.

Conclusions:

  • SCA12 represents a unique subtype of spinocerebellar ataxia.
  • The CAG repeat expansion in SCA12 may disrupt the expression of the PPP2R2B gene, affecting protein phosphatase 2A function.
  • Further research is needed to fully elucidate the molecular pathogenesis of SCA12.